Anaptyss

Logistics & Supply Chain

51-200 employees

Overview

AnaptyssBio is a clinical-stage biotechnology company focused on developing first-in-class antibodies for inflammation and immune-oncology. Their lead program, Imsidolimab (formerly ANB020), is a novel anti-IL-36R antibody in development for the treatment of generalized pustular psoriasis (GPP) and other inflammatory diseases. The company is also developing other pre-clinical programs targeting inflammatory and immune-oncology pathways.

Vision

To be a leading biotechnology company recognized for its groundbreaking research and development of novel therapeutics.

Mission

To develop and commercialize innovative therapies that improve the lives of patients with inflammatory and immune-oncology diseases.

Headquarters

New Delhi

Specialties & Industries

Antibody discoveryantibody engineeringimmunologyinflammationimmune-oncologydrug developmentclinical trialsbiopharmaceuticalsgeneralized pustular psoriasis (GPP)translational science.Management ConsultingInformation Technology & ServicesSupply Chain Technology ImplementationB2BService Based Company

Open Positions

No open positions at the moment

Check back later for new opportunities